4 unchanged sentences
001-38079), filed with the SEC on May 18, 2017).
+Added: Form of July 2023 Pre-Funded  
+Added: Warrant (incorporated by reference to Exhibit 4.1 to the Registrant ’
+Added: s Current Report on Form 8-K (File No.
+Added: 001-38079), filed with the SEC on July 27, 2023).
+Added: Manufacturing and Supply Agreement - Amendment No.
+Added: 2, dated May 19, 2023, by and between the Registrant and Isotopia Molecular Imaging Ltd.
+Added: Amendment to Loan Agreement, dated June 29, 2023, by and among the Company, UroGen Pharma, Inc., as the borrower, and certain direct and indirect subsidiaries of the Company party thereto from time to time, as guarantors, BPCR Limited Partnership, as a lender, BioPharma Credit Investments V (Master) LP, as a lender, and BioPharma Credit PLC, as collateral agent for the lenders.
+Added: Securities Purchase Agreement, dated July 26, 2023, by and among UroGen Pharma Ltd.
+Added: and the Purchasers named therein (incorporated by reference to Exhibit 10.1 to the Registrant’
+Added: s Current Report on Form 8-K (File No.
+Added: 001-38079), filed with the SEC on July 27, 2023).
Certification of Principal Executive Officer pursuant to Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
12 unchanged sentences
The information in Exhibits 32.1 and 32.2 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act (including this Quarterly Report), unless the Registrant specifically incorporates the foregoing information into those documents by reference.
+Added: Certain portions of this exhibit are omitted because they are not material and are the type that the Registrant treats as private and confidential.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
UroGen Pharma Ltd.
+Added: August 10, 2023
/s/ Elizabeth Barrett
2 unchanged sentences
(Principal Executive Officer)
+Added: August 10, 2023
Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.